Advertisement
Advertisement
U.S. markets open in 8 hours 26 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.6900+0.1400 (+3.94%)
At close: 04:00PM EDT
3.8400 +0.15 (+4.07%)
After hours: 07:50PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close3.5500
Open3.6100
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range3.6060 - 3.7600
52 Week Range2.3300 - 7.4000
Volume6,282
Avg. Volume17,290
Market Cap37.871M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.4870
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACXP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acurx Pharmaceuticals, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
Advertisement
Advertisement